Notes from the Aging Research and Drug Discovery 2021 Conference

The Longevity.technology team has been publishing notes on the recent Aging Research and Drug Discovery (ARDD) conference, one of the few events at the end of this year to be held in person again after the long pandemic hiatus. It was a challenge for conference organizers to look into the crystal ball six to twelve months in advance and commit to a late 2021 event, but some did. The 2022 conference season will no doubt be interesting, as restrictions relax sufficiently for reliable travel and advance scheduling, and a few years of the suppressed urge to network is finally unleashed. The ARDD conferences are more focused on academic science and the established pharmaceutical industry than on investment and entrepreneurship, at least in comparison to say, the Undoing Aging conference series, but it can nonetheless be an interesting event for both investors and entrepreneurs. For my part, I feel that there is too much of a focus on incremental, unambitious programs and interventions, such as metformin and other calorie restriction mimetics. These unambitious programs may turn out to provide sufficient proof of principle, in animal studies and preclinical drug discovery, for those leaders in the pharmaceutical industry who still find the idea of treating aging a novelty. The outcomes in the clinic will be modest to the point of pointlessness, however. No-one should be spending billions on the development of drugs that cannot in principle do any more for health than exercis...
Source: Fight Aging! - Category: Research Authors: Tags: Healthy Life Extension Community Source Type: blogs